164 related articles for article (PubMed ID: 8838267)
1. Clinical trials referral resource. High priority trials.
Oncology (Williston Park); 1996 Feb; 10(2):226, 229-30. PubMed ID: 8838267
[No Abstract] [Full Text] [Related]
2. [Treatment of small cell lung cancer].
Ueoka H; Ohnoshi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Moro D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
[No Abstract] [Full Text] [Related]
4. Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
Papacharalambous A; Rigatos G; Alexopoulos A; Stavrakakis J; Scartsilas C; Stavrinidis E
J Chemother; 1989 Jul; 1(4 Suppl):1214-5. PubMed ID: 16312839
[No Abstract] [Full Text] [Related]
5. Chemotherapy (CAV) and surgical resection as combined modality in the therapy of small-cell lung cancer.
Gatzemeier U; Radenbach D
Panminerva Med; 1986; 28(2):63-6. PubMed ID: 3022223
[No Abstract] [Full Text] [Related]
6. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
7. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Papadakis E
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
[No Abstract] [Full Text] [Related]
8. Rationale for clinical application of hyperthermia and drugs.
Engelhardt R
Strahlenther Onkol; 1987 Jul; 163(7):428-9. PubMed ID: 3039673
[No Abstract] [Full Text] [Related]
9. Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few.
Leo F; Solli P; Veronesi G; Catalano G; De Pas T; Petrella F; Spaggiari L
J Clin Oncol; 2007 May; 25(15):2146; author reply 2147. PubMed ID: 17513829
[No Abstract] [Full Text] [Related]
10. [Combined modality therapy of small cell lung cancer].
Zhao F; Ge B; Xin Y
Zhonghua Yi Xue Za Zhi; 1992 May; 72(5):310-2. PubMed ID: 1327463
[No Abstract] [Full Text] [Related]
11. Investigation chemotherapy in multimodality therapy of non-small cell lung cancer.
Vokes EE
Front Radiat Ther Oncol; 1992; 26():64-71. PubMed ID: 1324877
[No Abstract] [Full Text] [Related]
12. [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer].
Goldobenko GV; Kanaev SV
Vopr Onkol; 1998; 44(5):623-8. PubMed ID: 9884730
[No Abstract] [Full Text] [Related]
13. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
Kubota K
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
[TBL] [Abstract][Full Text] [Related]
14. Surgery for cure of small cell bronchial carcinoma (SCLC) at early stages and postoperative combined modality treatment.
Karrer K; Denck H; Karnicka-Mlodkowska H; Drings P; Erzen J; Salzer GM;
J Chemother; 1989 Jul; 1(4 Suppl):1207-8. PubMed ID: 16312836
[No Abstract] [Full Text] [Related]
15. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Yamaguchi M; Fukuyama Y; Ichinose Y
Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
[TBL] [Abstract][Full Text] [Related]
16. [International consensus for lung cancer treatment].
Naruse I; Saijo N
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():451-9. PubMed ID: 9369922
[TBL] [Abstract][Full Text] [Related]
17. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
Athanassiades P; Lagoudis M; Kostis E
J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
[No Abstract] [Full Text] [Related]
18. [Postoperative adjuvant treatment for non-small cell lung cancer].
Ichinose Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2470-4. PubMed ID: 12506468
[TBL] [Abstract][Full Text] [Related]
19. Optimal therapy for unresectable stage III non-small-cell lung cancer.
Vokes EE
J Clin Oncol; 2005 Sep; 23(25):5853-5. PubMed ID: 16087940
[No Abstract] [Full Text] [Related]
20. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
Mellqvist UH; Lenhoff S; Johnsen HE; Hjorth M; Holmberg E; Juliusson G; Tangen JM; Westin J;
Cancer; 2008 Jan; 112(1):129-35. PubMed ID: 17973267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
